[HTML][HTML] Comparison of a concurrent fluorouracil-based regimen and a taxane-based regimen combined with radiotherapy in elderly patients with esophageal …

C Huang, D Huang, Y Zhu, G Xie, H Wang, J Shi… - Translational …, 2020 - Elsevier
Treatment Patients who were treated with 5-Fu plus cisplatin with concurrent radiotherapy
were … Patients who were treated with taxanes (including docetaxel or paclitaxel) plus platinum (…

Selective use of concurrent chemotherapy in elderly cervical cancer patients treated with definitive radiotherapy: experience from two institutions

K You, H Peng, Y Jiang, Z Bi, X Qiu - Cancer Management and …, 2019 - Taylor & Francis
… outcomes in elderly patients receiving definitive radiotherapy is still … for elderly patients to
undergo concurrent chemotherapy. … which included paclitaxel plus cisplatin was also used, the …

[HTML][HTML] Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer

DY Kim, C Song, SH Kim, YJ Kim, JS Lee… - Radiation Oncology …, 2019 - ncbi.nlm.nih.gov
… This study evaluated the actual clinical outcomes between concurrent chemoradiotherapy
(… The regimens of concurrent CT were paclitaxel-cisplatin (n = 48), docetaxel-cisplatin (n = 3), …

… and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell …

C Huang, Y Zhu, Q Li, W Zhang, H Liu… - Cancer …, 2019 - Wiley Online Library
concurrent chemoradiotherapy with docetaxel plus cisplatin vs 5-Fluorouracil plus cisplatin
… the two groups, but the docetaxel plus cisplatin regimen was associated with more severe …

[HTML][HTML] Elderly patients with locally advanced and unresectable non-small-cell lung cancer may benefit from sequential chemoradiotherapy

M Zaborowska-Szmit, M Olszyna-Serementa… - Cancers, 2021 - mdpi.com
… in elderly patients diagnosed with unresectable locally advanced NSCLC was planned to
compare radiotherapy alone with a concurrent chemoradiotherapy. … carboplatin + paclitaxel. …

Survival after definitive chemoradiotherapy with concurrent cisplatin or carboplatin for head and neck cancer

M Xiang, AD Colevas, FC Holsinger, QTX Le… - Journal of the National …, 2019 - jnccn.org
… or hypopharynx who received definitive radiotherapy (RT) were … concurrent chemotherapy
regimen was determined through … The use of carboplatin and paclitaxel with daily radiotherapy

Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer

M Yamaguchi, H Hirata, N Ebi, J Araki… - Japanese Journal of …, 2020 - academic.oup.com
… When developing the CCRT regimen using platinum and vinorelbine, a phase II study for
induction chemotherapy followed by CCRT using cisplatin with gemcitabine, paclitaxel or …

[HTML][HTML] Concurrent liposomal paclitaxel and cisplatin chemotherapy improved outcomes for locally advanced esophageal squamous cell carcinoma treated with …

S Liu, SN Ren, WX Ding, XL Ge, YD Cao… - Annals of …, 2019 - ncbi.nlm.nih.gov
… To ascertain whether concurrent chemotherapy using liposomal paclitaxel and cisplatin
alone versus IMRT with concurrent paclitaxel plus cisplatin in treating locally advanced ESCC. …

[HTML][HTML] Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)

MA Socinski, M Özgüroğlu, A Villegas, D Daniel… - Clinical Lung Cancer, 2021 - Elsevier
… placebo in patients with unresectable, stage III NSCLC whose disease had not progressed
after platinum-based, concurrent chemoradiotherapy (CRT). We report exploratory analyses …

Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing definitive radiotherapy

A Rühle, S Marschner, M Haderlein, A Fabian… - JAMA network …, 2023 - jamanetwork.com
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus… use of multiagent
protocols without cisplatin, such as mitomycin C plus fluorouracil, carboplatin plus paclitaxel